Low-dose trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis ji

Background

Pneumocystis jirovecii pneumonia (PJP) is a respiratory infection disease and predominantly affects immunocompromised individuals. PJP is one of the leading causes of morbidity and mortality among patients infected with human…

Continue Reading